PDLI News and Press, PDL BioPharma Inc. From 11/11/20

PDL BioPharma, Inc. (PDLI) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Dominique Monnet – President and Chief Executive Officer Edward Imbrogno – Vice President and Chief Financial Officer Conferenc...

Gainers: [[FOSL]] +32.5%. [[IGT]] +12.4%. [[FPRX]] +12.2%. [[BEDU]] +10.8%. [[PDLI]] +9.3%.Losers: [[PNTG]] -12.0%. [[VRM]] -10.7%. [[RVLV]] -9.3%. [[SPTN]] -7.8%. [[ATRA]] -7.1%. For further details see: FOSL, IGT, PNTG and VRM among after-hours movers

PDL BioPharma (PDLI): Q3 GAAP EPS of -$0.64.Revenue of $7.1M (-12.3% Y/Y)Press Release For further details see: PDL BioPharma reports Q3 results

PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update Conference Call to Wednesday, November 11 at 4:30 p.m. Eastern Time PR Newswire INCLINE VILLAGE, Nev., Nov. 6, 2020 INCLINE VILLAGE, Nev. , Nov. 6, 2020 /PRNewswire/ -- ...

PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020 PR Newswire INCLINE VILLAGE, Nev., Oct. 29, 2020 INCLINE VILLAGE, Nev. , Oct. 29, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Com...

Gainers: American Renal Associates (ARA) +68%.IDT (IDT) +37%.Nano-X Imaging (NNOX) +36%.Westwater Resources (WWR) +24%.voxeljet (VJET) +21%.Houghton Mifflin Harcourt (HMHC) +21%.ProPhase Labs (PRPH) +19%.Lithium Americas (LAC) +19%.Telenav (TNAV) +18%.Assured Guaranty (AGO) +17...

Gainers: Aduro Biotech (ADRO) +442%, American Renal Associates (ARA) +69%, Nano-X Imaging (NNOX) +38%, CTI BioPharma (CTIC) +18%, ProPhase Labs (PRPH) +16%.Losers: Benitec Biopharma (BNTC) -36%, Mesoblast (MESO) -36%, Arcutis Biotherapeut...

PDL BioPharma (PDLI) completes the previously announced spin-off of its femtosecond laser system business, LENSAR.PDL stockholders received 0.075879 shares of LENSAR common stock for every 1 share of PDL common stock outstanding at 5:00 PM ET on Sept. 22, 2020, the record date for the sp...

PDL BioPharma Completes Spin-Off of LENSAR PR Newswire INCLINE VILLAGE, Nev., Oct. 2, 2020 INCLINE VILLAGE, Nev. , Oct. 2, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has completed the previous...

INCLINE VILLAGE, Nev. , Sept. 10, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced that its Board of Directors has approved the separation of LENSAR, Inc. ("LENSAR"), a majority owned subsidiary of PDL, from PDL in the form of a dividend invo...